Misoprostol is manufactured by several pharmaceutical companies, including but not limited to Pfizer, Teva Pharmaceuticals, and Mylan N.V. [1][2].
What is Misoprostol used for?
Misoprostol is a medication used to prevent stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It is also used to induce labor, manage postpartum hemorrhage, and for medical abortion [3].
When does Misoprostol patent protection expire?
The patent expiry dates for misoprostol vary depending on the specific formulation and the country. For instance, patents related to certain extended-release formulations may have different expiry timelines than the original immediate-release versions. Information on specific patent statuses can be found on resources like DrugPatentWatch.com [4].
Who are the main competitors for Misoprostol?
In the context of preventing NSAID-induced ulcers, misoprostol competes with other preventative medications and the development of alternative pain management strategies. For its obstetric and gynecological uses, competing treatments may include other prostaglandins or interventions depending on the specific indication [5].
How is Misoprostol regulated?
Misoprostol is regulated by health authorities like the U.S. Food and Drug Administration (FDA). Manufacturers must obtain approval for their specific products, demonstrating safety and efficacy through clinical trials. The prescribing information and labeling are subject to regulatory review and updates [3].